

Investment Rating - The investment rating for the company is "Accumulate" with a target price of 50.08 CNY per share [6][13]. Core Insights - The company's net profit increased by 11.0% year-on-year in the first half of 2025, with a significant improvement of 36.5% in Q2. This growth is attributed to improved investment returns [3][13]. - The embedded value increased by 4.7% year-to-date, primarily driven by expected returns and the positive contribution from new business value (NBV), which grew by 32.3% year-on-year in H1 2025 [3][13]. - The company has optimized its asset allocation, with a notable increase in bond allocation by 2.4 percentage points to 62.5% [13]. Financial Summary - Revenue for 2023 is projected at 323,945 million CNY, with a growth forecast of 25% for 2024, followed by a slight decline of 3% in 2025 [5]. - Net profit attributable to shareholders is expected to rise from 27,257 million CNY in 2023 to 44,960 million CNY in 2024, reflecting a 65% increase [5]. - The earnings per share (EPS) is projected to be 4.78 CNY in 2025, with a steady growth trajectory in subsequent years [5][14]. Business Performance - The life insurance NBV growth is primarily driven by a robust increase in new policy premiums, which rose by 28.7% year-on-year [13]. - The company’s property insurance combined ratio (COR) improved by 0.8 percentage points to 96.3%, indicating better operational efficiency [13]. - The company’s investment income is expected to improve, with a projected non-annualized net investment return of 1.7% in H1 2025 [13].